{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:26:54Z","timestamp":1793413614814,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1001\/jamaneurol.2020.5157","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T22:46:53Z","timestamp":1612219613000},"page":"407","source":"Crossref","is-referenced-by-count":87,"title":["Association of Glycolysis-Enhancing \u03b1-1 Blockers With Risk of Developing Parkinson Disease"],"prefix":"10.1001","volume":"78","author":[{"given":"Jacob E.","family":"Simmering","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Welsh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City"},{"name":"Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City"},{"name":"Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City"},{"name":"Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City"},{"name":"Howard Hughes Medical Institute, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[{"name":"Center of Stroke, Beijing Institute for Brain Disorders, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandakumar S.","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"noi200098r1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention.","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol"},{"issue":"6","key":"noi200098r2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"issue":"4","key":"noi200098r3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","article-title":"The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"5","key":"noi200098r4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00702-005-0341-1","article-title":"Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson\u2019s disease.","volume":"113","author":"Burghaus","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"noi200098r5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/jnnp.2004.057893","article-title":"Disease progression continues in patients with advanced Parkinson\u2019s disease and effective subthalamic nucleus stimulation.","volume":"76","author":"Hilker","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi200098r6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized delayed-start trial of levodopa in Parkinson\u2019s disease.","volume":"380","author":"Verschuur","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"noi200098r7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/acn3.2017.4.issue-6","article-title":"A novel design of a phase III trial of isradipine in early Parkinson disease (STEADY-PD III).","volume":"4","author":"Biglan","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"noi200098r8","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/mds.26354","article-title":"Disease-modifying strategies for Parkinson\u2019s disease.","volume":"30","author":"Kalia","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"noi200098r9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.v30.1","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics.","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"noi200098r10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1517\/14728222.2012.664135","article-title":"Bioenergetics failure in neurodegenerative diseases: back to the future.","volume":"16","author":"Saxena","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"noi200098r11","first-page":"245","article-title":"Brain glucose and energy metabolism during normal aging.","volume":"2","author":"Hoyer","year":"1990","journal-title":"Aging (Milano)"},{"issue":"1","key":"noi200098r12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nut.2010.07.021","article-title":"Brain fuel metabolism, aging, and Alzheimer\u2019s disease.","volume":"27","author":"Cunnane","year":"2011","journal-title":"Nutrition"},{"issue":"4","key":"noi200098r13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","article-title":"Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study.","volume":"88","author":"Firbank","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"pt 12","key":"noi200098r14","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1093\/brain\/awp293","article-title":"Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson\u2019s disease.","volume":"132","author":"Hattingen","year":"2009","journal-title":"Brain"},{"issue":"6","key":"noi200098r15","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/jnc.1990.55.issue-6","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease.","volume":"55","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"issue":"3","key":"noi200098r16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/jnc.1990.54.issue-3","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease.","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"key":"noi200098r17","doi-asserted-by":"publisher","first-page":"216.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.033","article-title":"Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease.","volume":"38","author":"Pyle","year":"2016","journal-title":"Neurobiol Aging"},{"key":"noi200098r18","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson\u2019s disease.","volume":"2012","author":"Blesa","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"noi200098r19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease.","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol"},{"issue":"12","key":"noi200098r20","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1007\/s11064-008-9855-x","article-title":"Mitochondrial dysfunction in neurodegenerative diseases.","volume":"33","author":"Schapira","year":"2008","journal-title":"Neurochem Res"},{"issue":"1","key":"noi200098r21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nchembio.1657","article-title":"Terazosin activates Pgk1 and Hsp90 to promote stress resistance.","volume":"11","author":"Chen","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"10","key":"noi200098r22","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","article-title":"Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases.","volume":"129","author":"Cai","year":"2019","journal-title":"J Clin Invest"},{"issue":"6","key":"noi200098r23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/009127009203200605","article-title":"Terazosin: a new alpha adrenoceptor blocking drug.","volume":"32","author":"Achari","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"noi200098r24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000052324","article-title":"Modulation of voiding and storage reflexes by activation of a1-adrenoceptors.","volume":"36","author":"de Groat","year":"1999","journal-title":"Eur Urol"},{"issue":"3","key":"noi200098r25","first-page":"798","article-title":"Data resource profile: the Danish National Prescription registry.","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"noi200098r26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP","article-title":"The Danish National Patient registry: a review of content, data quality, and research potential.","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"issue":"8","key":"noi200098r27","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology.","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"noi200098r29","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1212\/WNL.0b013e3182684707","article-title":"Recommendations for optimal ICD codes to study neurologic conditions: a systematic review.","volume":"79","author":"St Germaine-Smith","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"noi200098r30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mds.22283","article-title":"Optimizing algorithms to identify Parkinson\u2019s disease cases within an administrative database.","volume":"24","author":"Szumski","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"noi200098r31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"noi200098r32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/joim.12197","article-title":"Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.","volume":"275","author":"St\u00fcrmer","year":"2014","journal-title":"J Intern Med"},{"issue":"19","key":"noi200098r33","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.2018.285.issue-19","article-title":"Determinants of dopaminergic neuron loss in Parkinson\u2019s disease.","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J"},{"issue":"11","key":"noi200098r34","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies.","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5646","key":"noi200098r35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson\u2019s disease.","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"issue":"6339","key":"noi200098r36","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aaf6846","article-title":"ATP as a biological hydrotrope.","volume":"356","author":"Patel","year":"2017","journal-title":"Science"},{"key":"noi200098r37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7554\/eLife.35224","article-title":"Dual roles for ATP in the regulation of phase separated protein aggregates in Xenopus oocyte nucleoli.","volume":"7","author":"Hayes","year":"2018","journal-title":"Elife"},{"key":"noi200098r28","unstructured":"World Health Organization. Guidelines for ATC classification and DDD assignment. Accessed February 21, 2019. https:\/\/www.whocc.no\/atc_ddd_index_and_guidelines\/guidelines\/"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2775976\/jamaneurology_simmering_2021_oi_200098_1617209051.41766.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:59:10Z","timestamp":1617886750000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2775976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.5157","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}